A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PILOT STUDY TO EVALUATE THE SAFETY AND EFFECT OF CINRYZE FOR THE PREVENTION OF DELAYED GRAFT FUNCTION (DGF) IN RECIPIENTS OF DECEASED DONOR KIDNEY ALLOGRAFTS
|Effective start/end date||10/1/11 → 8/5/13|
- ViroPharma Incorporated
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.